Table 1 Clinical data of patients with type 2 diabetes
VFA (cm2) | <100 | ≥100 | p value* | ||
|---|---|---|---|---|---|
SFA (cm2) | <100 (N = 34) | ≥100 (N = 39) | <100 (N = 11) | ≥100 (N = 64) | |
VFA (cm2) | 56 ± 26 | 74 ± 21 | 149 ± 34 | 175 ± 52 | <0.001 |
SFA (cm2) | 61 ± 23 | 157 ± 41 | 78 ± 16 | 149 ± 34 | <0.001 |
VFA-to-SFA ratio | 1.00 ± 0.43 | 0.50 ± 0.20 | 1.98 ± 0.62 | 0.92 ± 0.33 | <0.001 |
Age (years) | 70 ± 10 | 64 ± 11 | 72 ± 6 | 62 ± 12 | 0.001 |
Gender (% male) | 77 | 18 | 100 | 59 | <0.001 |
BMI (kg/m2) | 19.4 ± 2.1 | 23.2 ± 2.4 | 22.5 ± 1.8 | 27.0 ± 3.8 | <0.001 |
SBP (mmHg) | 118 ± 15 | 115 ± 9 | 136 ± 13 | 129 ± 11 | <0.001 |
DBP (mmHg) | 68 ± 11 | 66 ± 9 | 78 ± 15 | 75 ± 12 | <0.001 |
Current smoker (%) | 0 | 5 | 18 | 11 | 0.111 |
Duration of diabetes (years) | 4.9 (4.2–5.7) | 2.6 (2.2–3.2) | 3.8 (3.0–4.8) | 3.2 (3.1–3.3) | 0.120 |
HbA1c (%) | 6.9 ± 1.0 | 6.7 ± 0.4 | 6.7 ± 0.4 | 7.4 ± 1.7 | 0.024 |
Triglycerides (mmol/l) | 1.36 (1.15–1.61) | 1.01 (0.88–1.16) | 1.16 (0.79–1.69) | 1.67 (1.43–1.96) | 0.001 |
HDL cholesterol (mmol/l) | 1.48 ± 0.52 | 1.50 ± 0.58 | 1.61 ± 0.42 | 1.52 ± 0.44 | 0.900 |
LDL cholesterol (mmol/l) | 2.42 ± 0.72 | 2.80 ± 1.05 | 2.80 ± 0.75 | 2.95 ± 0.82 | 0.052 |
Uric acid (μmol/l) | 282 ± 85 | 265 ± 82 | 395 ± 91 | 335 ± 58 | <0.001 |
eGFR (ml/min/1.73 m2) | 76.8 ± 18.1 | 73.0 ± 21.5 | 62.3 ± 22.6 | 70.6 ± 23.4 | 0.250 |
Log ACR (mg/g) | 24 (18–31) | 23 (15–35) | 25 (11–55) | 45 (31–68) | <0.001 |
PDR (%) | 6 | 0 | 0 | 11 | 0.128 |
AST (U/l) | 25 (23–27) | 21 (19–24) | 27 (22–34) | 25 (23–28) | 0.060 |
ALT (U/l) | 21 (17–25) | 16 (14–17) | 21 (14–31) | 27 (23–31) | <0.001 |
γ-GTP (U/l) | 26 (23–31) | 23 (21–25) | 64 (37–112) | 41 (29–59) | <0.001 |
CIMT (mm) | 0.86 ± 0.17 | 0.88 ± 0.07 | 1.30 0.41 | 0.81 ± 0.17 | <0.001 |